Biblio Discovery — Demo Discovery Service

2 hasil

Menampilkan 1–2 · 0,08 detik · RSS

Jurnal

American Heart Journal

Scopus

ISSN 0002-8703 · Elsevier BV · 2 artikel di indeks

  1. Artikel Jurnal

    Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS‐CVOT design and baseline characteristics

    Stephen James Nicholls; Deepak L. Bhatt; John B. Buse dkk.

    American Heart Journal · 2023 · Inggris · OpenAlex Scopus

    Tirzepatide, a once weekly GIP/GLP-1 receptor agonist, reduces blood glucose and body weight in people with type 2 diabetes. The cardiovascular (CV) safety and efficacy of tirzepatide have not been definitively assessed in a cardiovascular outcomes trial. Tirzepatide is being studied in a…

  2. Artikel Jurnal Teks lengkap

    Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design

    Donna H. Ryan; Ildiko Lingvay; Helen Martina Colhoun dkk.

    American Heart Journal · 2020 · Inggris · OpenAlex Scopus

    Cardiovascular disease (CVD) is a major cause of morbidity and mortality. Although it has been widely appreciated that obesity is a major risk factor for CVD, treatments that produce effective, durable weight loss and the impact of weight reduction in reducing cardiovascular risk have been elusive…